Needle Free Diabetes Management Market: Global Industry Size, Share, Growth, Opportunities, Outlook, Analysis and Forecast 2017 To 2025

According to a recently published report by Brisk Insights, the Global Needle Free Diabetes Management Market is expected to grow at the CAGR of 16.6 % during 2017-2025. The global needle free diabetes management market is segmented on the basis of device type and geography. The report on global needle free diabetes management market (by device type and geography) provides a detailed overview and predictive analysis of the market.

Full report available on Needle Free Diabetes Management Market: Global Industry Size, Growth, Share and Forecast to 2025 report at http://www.briskinsights.com/report/needle-free-diabetes-management-market

Market Insights

Patient convenience and rising public awareness regarding the availability of needle- free diabetes management devices are the key growth factors in the needle free diabetes management market. In base year 2016, insulin pens and jet injectors collectively accounted for the largest market share of around 51% of the overall needle-free diabetes treatment market as they are one of the most initial treatment solutions available in the market, high market penetration and high public awareness are key driving factors. The needle free diabetes management market is currently dominated by North America due to increasing number of patients suffering with diabetes, rising public awareness, and supportive reimbursement policies. On the other hand, Asia-Pacific is anticipated to be the fastest growing market because of deep market penetration due to increasing prevalence of diabetes, early disease diagnosis and developing healthcare infrastructure.

Scope of the report

1. Global Needle free diabetes management market, by Device Type, 2015–2025 ($ Million)

1.1. Treatment devices
1.1.1. Insulin jet injector
1.1.2. Insulin pen
1.1.3. Insulin inhaler
1.1.4. Insulin patch and pump
1.2. Diagnostic devices
1.2.1. Continuous glucose monitoring (CGM) system
1.2.2. Flash glucose monitoring (FGM) system
1.3. Artificial pancreas

Browse Here For Same Category Report: http://www.briskinsights.com/category/pharmaceutical-industry

2. Global Needle free diabetes management market, by Geography, 2015-2025 ($ Million)

2.1. North America
2.1.1. U.S.
2.1.2. Canada
2.2. Europe
2.2.1. U.K.
2.2.2. Germany
2.2.3. Rest of Europe
2.3. Asia Pacific
2.3.1. Japan
2.3.2. China
2.3.3. Rest of Asia Pacific
2.4. Latin America
2.4.1. Mexico
2.4.2. Brazil
2.4.3. Rest of Latin America
2.5. Middle East and Africa
2.5.1. GCC
2.5.2. Rest of Middle East and Africa

3. Company Profiles

3.1. Antares Pharma Inc.
3.2. Akra Dermojet
3.3. Bioject Medical Technologies, Inc.
3.4. Glide Pharmaceutical Technologies Ltd.
3.5. Injex Pharma AG
3.6. JDRF
3.7. Johnson & Johnson, Inc.
3.8. 3M
3.9. Medtronic, Inc.
3.10. Pancreum LLC
3.11. Pharmajet, Inc.
3.12. Tandem Diabetes Care, Inc.
3.13. Zogenix, Inc.

Download Free Request Sample : http://www.briskinsights.com/sample-request/631

Blog: http://briskinsightsresearchreports.blogspot.in/

About Us :

Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities optimize strategies.
Working in a highly dynamic and multi-dimensional business makes decision making complex. Effective business decisions are a result of the synthesis of market information. Our Research and data analysis is an efficient and cost-effective way of providing robust market analysis and can yield highly valuable intelligence relating to consumers, competitors and markets.

Contact Us :

Jennifer Smith
Office 1094
109 Vernon House
Friar Lane
Nottingham
NG1 6DQ
United Kingdom
Phone : +448081890034 (UK)
Email : sales@briskinsights.com
Website : http://www.briskinsights.com/

Designed by CyFocus.com
Powered by CyFocus.net